Clinical Trials Browser

OTHER × Ovarian Neoplasms × Ashwagandha × Clear all

NCT05610735 2026-03-19

Combination Therapy for Recurrent Ovarian Cancer

Phase 1/2 Recruiting

Ovarian Neoplasms